Correlation Between Cadrenal Therapeutics, and NewAmsterdam Pharma
Can any of the company-specific risk be diversified away by investing in both Cadrenal Therapeutics, and NewAmsterdam Pharma at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Cadrenal Therapeutics, and NewAmsterdam Pharma into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Cadrenal Therapeutics, Common and NewAmsterdam Pharma, you can compare the effects of market volatilities on Cadrenal Therapeutics, and NewAmsterdam Pharma and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Cadrenal Therapeutics, with a short position of NewAmsterdam Pharma. Check out your portfolio center. Please also check ongoing floating volatility patterns of Cadrenal Therapeutics, and NewAmsterdam Pharma.
Diversification Opportunities for Cadrenal Therapeutics, and NewAmsterdam Pharma
0.68 | Correlation Coefficient |
Poor diversification
The 3 months correlation between Cadrenal and NewAmsterdam is 0.68. Overlapping area represents the amount of risk that can be diversified away by holding Cadrenal Therapeutics, Common and NewAmsterdam Pharma in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on NewAmsterdam Pharma and Cadrenal Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Cadrenal Therapeutics, Common are associated (or correlated) with NewAmsterdam Pharma. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of NewAmsterdam Pharma has no effect on the direction of Cadrenal Therapeutics, i.e., Cadrenal Therapeutics, and NewAmsterdam Pharma go up and down completely randomly.
Pair Corralation between Cadrenal Therapeutics, and NewAmsterdam Pharma
Given the investment horizon of 90 days Cadrenal Therapeutics, Common is expected to under-perform the NewAmsterdam Pharma. In addition to that, Cadrenal Therapeutics, is 1.19 times more volatile than NewAmsterdam Pharma. It trades about -0.03 of its total potential returns per unit of risk. NewAmsterdam Pharma is currently generating about 0.1 per unit of volatility. If you would invest 1,913 in NewAmsterdam Pharma on August 28, 2024 and sell it today you would earn a total of 171.00 from holding NewAmsterdam Pharma or generate 8.94% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Significant |
| Accuracy | 100.0% |
| Values | Daily Returns |
Cadrenal Therapeutics, Common vs. NewAmsterdam Pharma
Performance |
| Timeline |
| Cadrenal Therapeutics, |
| NewAmsterdam Pharma |
Cadrenal Therapeutics, and NewAmsterdam Pharma Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Cadrenal Therapeutics, and NewAmsterdam Pharma
The main advantage of trading using opposite Cadrenal Therapeutics, and NewAmsterdam Pharma positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Cadrenal Therapeutics, position performs unexpectedly, NewAmsterdam Pharma can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in NewAmsterdam Pharma will offset losses from the drop in NewAmsterdam Pharma's long position.| Cadrenal Therapeutics, vs. Eliem Therapeutics | Cadrenal Therapeutics, vs. Scpharmaceuticals | Cadrenal Therapeutics, vs. Milestone Pharmaceuticals | Cadrenal Therapeutics, vs. Seres Therapeutics |
| NewAmsterdam Pharma vs. Eliem Therapeutics | NewAmsterdam Pharma vs. Scpharmaceuticals | NewAmsterdam Pharma vs. Milestone Pharmaceuticals | NewAmsterdam Pharma vs. Seres Therapeutics |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the ETFs module to find actively traded Exchange Traded Funds (ETF) from around the world.
Other Complementary Tools
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Sign In To Macroaxis Sign in to explore Macroaxis' wealth optimization platform and fintech modules | |
| Stock Screener Find equities using a custom stock filter or screen asymmetry in trading patterns, price, volume, or investment outlook. | |
| Crypto Correlations Use cryptocurrency correlation module to diversify your cryptocurrency portfolio across multiple coins | |
| USA ETFs Find actively traded Exchange Traded Funds (ETF) in USA |